KAIROS PHARMA LTD
KAPA·48301N104·US·Common Stock·Healthcare - Biotechnology-13D/G
KAPA (KAIROS PHARMA LTD) is held by 12 institutional investors as of Q2 2026. Largest holders: CITADEL ADVISORS LLC ($118,883), VANGUARD CAPITAL MANAGEMENT LLC ($89,041), GEODE CAPITAL MANAGEMENT, LLC ($30,282). Net institutional sentiment: Mixed.
12
Holders
(1 Elite)
$321,601
Total Value
64% (11)
Consensus
7 buying - 4 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 27, 2026 · Insiders none · Activists Aug 14, 2025 · Congress none
ActivistARArmistice Capital, LLC5.0%Aug 14, 2025
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer